London: More twins are being born now than ever before, largely due to rising use of in vitro fertilisation (IVF) and other assisted...
London: More twins are being born now than ever before, largely due to rising use of in vitro fertilisation (IVF) and other assisted...
Former rugby union and soccer players have called on fans in the UK to "lend their brain" for a new study examining the...
Istanbuil: More than 40 out of 100 people play mobile games at least once a day, according to a recent survey. AdColony, global...
Tucked in the Tuscan hills around Siena in Italy, a research lab has come up with an antibody treatment for Covid-19 that its...
LONDON - A highly transmissible COVID-19 variant that emerged in Brazil and has now been found in at least 20 countries can re-infect...
Geneva: Nearly 2.5 billion people worldwide or 1 in 4 people will be living with some degree of hearing loss by 2050, warns...
LONDON: Thousands of COVID-19 patients continue to suffer serious, debilitating and lingering symptoms many months after their initial bout of infection, with major...
The Pfizer and BioNTech Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication...
Are the management options same for all speech language disorders? Speech language interventions for different speech language disorders are not the same. Although...
NEW DELHI: What if COVID-19 never goes away? Experts say it's likely that some version of the disease will linger for years. But...
AstraZeneca's COVID-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as the...
A commonly used asthma treatment appears to reduce the need for hospitalizations as well as recovery time for COVID-19 patients if given within...
GENEVA: AstraZeneca's Chief Executive said on Tuesday that the results of a study showing its COVID-19 vaccine had little effect against mild disease...
When will the pandemic end? It’s the question hanging over just about everything since Covid-19 took over the world last year. The answer...
British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease...
LONDON: British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is...
AstraZeneca’s Covid-19 vaccine shows a hint that it may reduce transmission of the virus and offers strong protection for three months on just...
Geneva: Breast cancer has overtaken lung cancer as the most common form of the disease, accounting for nearly 12% of new cases each...
